Literature DB >> 9886142

Physiological, pathophysiological and therapeutic roles of 5-HT systems in learning and memory.

A Meneses1.   

Abstract

Multiple 5-hydroxytryptamine (5-HT) receptors have been identified (5-HT1A/1B/1D/1E/1F, 5-HT2A/2B/2C, 5-HT3A/3B, 5-HT4A/4B, 5-HT5A/5B, 5-HT6 and 5-HT7A/7B/7C/7D) and extensive evidence suggests that 5-HT receptors have a role in learning and memory. Indeed, available evidence strongly supports physiological, pathophysiological and therapeutic roles of 5-HT systems in cognitive processes, although the evidence seems incomplete. Indeed, there has been a clear tendency to use pre-learning administration most frequently, whereas post-learning and pre-retention administration protocols have been utilized in only a few studies, and probably this trend has led to missed relevant information. For instance, when pre- vs post-training administration of 5-HT1A agonist, 5-HT2 antagonists and 5-HT4 agonists have been compared contrasting findings were reported in aversive and appetitive learning tasks. Emerging evidence also indicates that 5-HT1A and 5-HT4 receptor agonists, as well as, 5-HT1A antagonists, 5-HT2 antagonists, 5-HT3 antagonists and 5-HT uptake inhibitors may have therapeutic utility in the treatment of Alzheimer's disease and amnesia. Inasmuch as the activation or blockade of diverse 5-HT receptors is able to modulate cognitive processes, and 5-HT uptake inhibition could have therapeutic applications in the treatment of cognitive disorders, it seems evident that the role of 5-HT in learning and memory is more complex than a simple imbalance. Consequently, the notion that activation of the 5-HT systems impairs performance, whereas reduced serotonergic function may facilitate learning, must be reconsidered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9886142     DOI: 10.1515/revneuro.1998.9.4.275

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  17 in total

1.  Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning.

Authors:  Laurel A Graves; Elizabeth A Heller; Allan I Pack; Ted Abel
Journal:  Learn Mem       Date:  2003 May-Jun       Impact factor: 2.460

2.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

Authors:  Alvin V Terry; Jerry J Buccafusco; Gerd D Bartoszyk
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

3.  Metabolism and receptor binding of serotonin in brain structures during performance of a conditioned passive avoidance response.

Authors:  G F Molodtsova
Journal:  Neurosci Behav Physiol       Date:  2005-09

4.  Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence.

Authors:  Lyngine H Calizo; Adaure Akanwa; Xiaohang Ma; Yu-Zhen Pan; Julia C Lemos; Caryne Craige; Lydia A Heemstra; Sheryl G Beck
Journal:  Neuropharmacology       Date:  2011-04-16       Impact factor: 5.250

5.  Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A.

Authors:  N I Dubrovina; N K Popova; M A Gilinskii; R A Tomilenko; I Seif
Journal:  Neurosci Behav Physiol       Date:  2006-05

6.  BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse.

Authors:  Véronique Lelong; Laurent Lhonneur; François Dauphin; Michel Boulouard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-05-08       Impact factor: 3.000

7.  Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.

Authors:  M Diez-Ariza; C Redondo; M García-Alloza; B Lasheras; J Del Río; M J Ramírez
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

8.  Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats.

Authors:  Hélène Jeltsch; Fabrice Bertrand; Rodrigue Galani; Christine Lazarus; Sarah Schimchowitsch; Jean-Christophe Cassel
Journal:  Psychopharmacology (Berl)       Date:  2004-03-11       Impact factor: 4.530

Review 9.  Molecular signaling involved in regulating feeding and other motivated behaviors.

Authors:  Todd R Gruninger; Brigitte LeBoeuf; Yishi Liu; L Rene Garcia
Journal:  Mol Neurobiol       Date:  2007-02       Impact factor: 5.590

10.  Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study.

Authors:  Felix Hasler; Ulrike Grimberg; Marco A Benz; Theo Huber; Franz X Vollenweider
Journal:  Psychopharmacology (Berl)       Date:  2003-11-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.